Acquiring Company
The Mark Foundation for Cancer Research
Acquired Company
Samuel Waxman Cancer Research Foundation
New YorkWashingtonBiotechnologyHealth CareNon ProfitBiotechnologyHealth CareMedicalDescription
The Mark Foundation for Cancer Research has merged with the Samuel Waxman Cancer Research Foundation, enhancing their collaborative efforts in cancer and aging research. The new partnership aims to advance innovative science and new treatments for cancer patients. The merger formalizes a previously established partnership that began in 2022.
Quick answer
The Mark Foundation for Cancer Research is acquiring Samuel Waxman Cancer Research Foundation, announced April 1, 2026. The Mark Foundation for Cancer Research is based in New York, New York, United States.
- How much did The Mark Foundation for Cancer Research pay for Samuel Waxman Cancer Research Foundation?
- The deal value was not disclosed.
- What does The Mark Foundation for Cancer Research do?
- The Mark Foundation for Cancer Research is a charitable organization that partners with scientists globally to accelerate research in cancer prevention, diagnosis, and treatment.
- Where are The Mark Foundation for Cancer Research and Samuel Waxman Cancer Research Foundation based?
- The Mark Foundation for Cancer Research is based in New York, New York, United States. Samuel Waxman Cancer Research Foundation is based in Washington, United States.
- Who are the decision-makers at The Mark Foundation for Cancer Research?
- Fundz holds 1 contact at The Mark Foundation for Cancer Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Non Profit and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
- Panthera Biopartners acquires OEC in Hungary (April 26, 2026)
- WCG to acquire The Contract Network for enhanced AI (April 21, 2026)
- Lupin completes acquisition of VISUfarma (April 2, 2026)
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- PhaseWell Research acquires Chase Medical Research (March 18, 2026)
Who to call at The Mark Foundation for Cancer Research, and when
When The Mark Foundation for Cancer Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day The Mark Foundation for Cancer Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at The Mark Foundation for Cancer Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at The Mark Foundation for Cancer Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment The Mark Foundation for Cancer Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Samuel Waxman Cancer Research Foundation?
Samuel Waxman Cancer Research Foundation was acquired by The Mark Foundation for Cancer Research, based in New York. The deal was reported on April 1, 2026. The Mark Foundation for Cancer Research is a charitable organization that partners with scientists globally to accelerate research in cancer prevention, diagnosis, and treatment. The Mark Foundation for Cancer Research is privately held and operates in Biotechnology.
When did The Mark Foundation for Cancer Research acquire Samuel Waxman Cancer Research Foundation?
The Mark Foundation for Cancer Research's acquisition of Samuel Waxman Cancer Research Foundation was reported on April 1, 2026. The Mark Foundation for Cancer Research has merged with the Samuel Waxman Cancer Research Foundation, enhancing their collaborative efforts in cancer and aging research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Samuel Waxman Cancer Research Foundation do?
The Samuel Waxman Cancer Research Foundation has been a key player in cancer research since 1976, distributing over $120 million to more than 200 scientists worldwide. It aims to advance cancer research with innovative approaches and collaborations. It is privately held, operating in Biotechnology, and is based in Washington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.